Elanco Animal Health Inc ELAN

US Pharmaceuticals

$26.37 ▼ -0.34% ($-0.09)

⬇️ Below Yest. Low 📅 Earnings This Week

Open $26.46

Prev Close $26.46

Day Range $25.77 – $26.47

52W Range $13.39 – $27.72

Market Cap $13.17B

Beta 1.71

EPS (TTM) $-0.51

📋 Company Profile

Industry	Pharmaceuticals
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2018-09-20
Shares Out.	499,450,000
Website	elanco.com/ ↗
Phone	18773526261
Employees	9,900
Revenue	$1.37B
Gross Profit	$785.0M
Net Income	$57.0M
Free Cash Flow	$315.0M
Total Assets	$13.22B
Total Liabilities	$6.72B
Equity	$6.50B

About Elanco Animal Health Inc

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.

Elanco Animal Health Inc is a publicly traded company under the ticker symbol ELAN on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.